Skip to content
Screener

Insulet PODD Accounts Receivable, Credit Loss Expense (Reversal)

Accounts Receivable, Credit Loss Expense (Reversal) at other companies

Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$3.25M+51.4%
Omada Health logo
Omada HealthOMDA
$383K+372%
Medtronic logo
MedtronicMDT
Beta Bionics logo
Beta BionicsBBNX
InfuSystem Holdings logo
InfuSystem HoldingsINFU
AptarGroup logo
AptarGroupATR

Other financials

Income statement

See full
Revenue$801.7M+23.5%
Gross profit$562.6M+24.4%
Operating income$129.7M+7.1%
Net income$95.0M+322%
EPS (diluted)$1.37+328%

Balance sheet

See full
Cash & equivalents$534.9M-52.3%
Total debt$974.7M-47.6%
Total equity$1.4B-2.8%
Total assets$3.2B-8.8%

Cash flow

See full
Operating cash flow$88.4M-55.0%
CapEx$32.5M+74.7%
Free cash flow$55.9M-68.6%

Valuation

See full
Market cap$9.91B-53.8%
Enterprise value$10.35B-53.4%
P/E26.4×-64.5×
P/S3.2×-5.8×

Profitability

See full
Gross margin71.1%+0.3pp
Operating margin16.9%-0.4pp
Net margin12.3%+2.3pp
FCF margin9.6%-7.5pp

Returns & leverage

See full
Return on equity26%+6.8pp
Debt / equity0.7×-0.6×
Current ratio2.5×+0.2×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The source filing: Insulet’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001145197-26-000169
(in millions)Six Months Ended / 2026Six Months Ended / 2025
Non-cash interest expense1.44.6
Loss on extinguishment of debt123.9
Deferred income taxes15.27.0
Provision for credit losses0.75.1
Other(0.5)4.0
Changes in operating assets and liabilities:
Accounts receivable(76.9)(41.8)
Accounts receivable - related party(25.1)

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Insulet's accounts receivable, credit loss expense (reversal)?
Insulet (PODD) reported accounts receivable, credit loss expense (reversal) of $400K in Q2 2026.
How has Insulet's accounts receivable, credit loss expense (reversal) changed year-over-year?
Insulet's accounts receivable, credit loss expense (reversal) decreased by 0.0% year-over-year, from $400K to $400K.
What is the long-term trend for Insulet's accounts receivable, credit loss expense (reversal)?
Over 3 years (2021 to 2024), Insulet's accounts receivable, credit loss expense (reversal) has grown at a -54.1% compound annual growth rate (CAGR), from $3.1M to -$300K.
What does accounts receivable, credit loss expense (reversal) mean?
Accounts Receivable, Credit Loss Expense (Reversal)

Ask your AI about Insulet's accounts receivable, credit loss expense (reversal).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude